Research programme: protein kinase TTK inhibitors - Netherlands Translational Research CenterAlternative Names: NTRC 00660
Latest Information Update: 03 Jun 2016
At a glance
- Originator Netherlands Translational Research Center
- Class Small molecules
- Mechanism of Action TTK protein inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours